A Feasibility Study Comparing Usual Foot Education and Phone App Alerts in Patients With Increased Risk of Diabetic Foot
A Feasibility Study to Compare Usual Methods of Patient Education With a Multi-media Presentation and Weekly 'Foot-alerts' Using 21st Century Technologies to Improve Patient Diabetic Foot Care Knowledge and Practices
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this study is to compare foot care knowledge, behaviour and glycaemic control in patients at increased risk of diabetic foot ulcers. Participants will receive either usual diabetic foot care education and follow-up as per evidence-based guidelines or usual care and follow-up, supplemented with an educational video and weekly foot alerts via a phone application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2019
CompletedFirst Submitted
Initial submission to the registry
March 6, 2019
CompletedFirst Posted
Study publicly available on registry
May 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedAugust 17, 2022
August 1, 2021
4 years
March 6, 2019
August 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in foot care knowledge as measured by the adapted foot care knowledge test
Change in the adapted Diabetic Foot Care Knowledge test (Pollock et al. 2004 and Rheeder et al. 2008) score between baseline and 12-months in the two groups This 12-question test has a maximum score of 12, and a minimum score of 0. Each correct answer is given one point, where a low score denotes low knowledge and high score denotes high knowledge. For each group a mean will be calculated and significance of differences will be tested using the students two tailed unpaired T-Test.
12 months
Change in foot care behaviour as measured by the SDSCA
SDCS questionnaire includes a number of domains which evaluate different aspects of patient behaviour performed during the previous week. Each domain has one or more questions that are marked between 0-7. The domains are: 1. Foot care: total of 9 questions with maximum score 9x7 = 63, the greater the score the better the behaviour 2. Diabetes Management: 4 questions in diabetes management, maximum score 4x7 = 28, the greater the score the better the behaviour 3. Smoking habits: number of cigarettes per day, the greater the number the worse the behaviour These measures allow formulation of a composite reflection in changes in the patient's behaviour between baseline and 12-months in the two groups. Differences will be tested using the students two-tailed unpaired T-Test.
12 months
Secondary Outcomes (2)
Change in HbA1c from baseline
12 months
Proportion of participants who developed a new diabetic foot ulcer
12 months
Study Arms (2)
Phone application arm
EXPERIMENTALParticipants will have access to a educational video and foot alerts at weekly intervals to supplement usual Podiatry care and education.
Usual care
OTHERParticipants will have Podiatry care and education.
Interventions
Weekly foot alerts and educational video
Usual routine of diabetic foot education
Eligibility Criteria
You may qualify if:
- Male or female 21 yrs or
- Type 2 Diabetes Mellitus or Type 1 Diabetes Mellitus greater than 5-yrs
- At least one diabetic foot risk factor (i.e Loss of Pain Sensation Peripheral Arterial Disease etc)
- Ability to understand Arabic or English to a skill listening level 3 and speaking level +2 (Interagency Language Roundtable).
- Own a smartphone and access to the internet
- The ability to understand the study procedures and to comply with them for the entire length of the study
- Resident in Kuwait
You may not qualify if:
- Chronic kidney disease stage 3 or above
- Cognitive impairment
- Acute psychiatric illness
- Hearing or visual impairment that would mean the intervention would not be understood
- phone application inaccessible for more than 4 continuous weeks
- Refusal to give written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dasman Diabetes Institute
Kuwait City, Kuwait
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kay Scarsbrook Khan, BSc
Dasman Diabetes Institute
- PRINCIPAL INVESTIGATOR
Ebaa Al Ozairi, MD
Dasman Diabetes Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2019
First Posted
May 2, 2019
Study Start
February 10, 2019
Primary Completion
February 1, 2023
Study Completion
April 1, 2023
Last Updated
August 17, 2022
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share